Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis

Autor: Stewart, Paul, Blanchette, Phillip, Shah, Prakesh S., Ye, Xiang Y., Boldt, R. Gabriel, Fernandes, Ricardo, Vandenberg, Ted, Raphael, Jacques
Zdroj: In The Breast December 2020 54:203-210
Databáze: ScienceDirect
Externí odkaz: